Successful seasonal flu vaccine development depends on protecting the world's population against the top 3-4 strains that are expected to be in circulation for the flu season. Keeping track of the flu requires a combination of precision tools, carefully managed processes and high caliber scientific and regulatory expertise.

Download our insight brief and learn 6 critical ways to keep track of the flu to optimize your seasonal flu vaccine development clinical trials. Q² Solutions' experts understand the critical success factors to support your needs for the development of safe and effective vaccines in time to protect people from seasonal flu.

Authors:
Wayne Hogrefe, Ph.D., D (ABMLI), Vice President, Q² Solutions
Sorika van Niekerk MSc, UP, SA, Senior Director, Q² Solutions
Ayaskant Pany, M.D., Director, Q² Solutions

Complete the form below to access this insight brief